Movement Alert|Synopsys Intraday Decline 3.12%, market digests recent price-target increases amid short-term volatility

Market Focus11-11

On November 11, Synopsys fell 3.12% in Regular Trading, trading at $452.49 per share, with turnover of $203 million.

The latest publicly available catalyst tied to the move is continued market digestion of recent analyst target-price increases after a prior sentiment boost, with short-term volatility emerging despite a still-supportive sell-side backdrop.

Recent analyst actions remained constructive: Rothschild & Co Redburn raised its target price to $615 from $550, above the broader analyst mean target of $594.87, while Needham, KeyBanc, and Morgan Stanley had also lifted targets to $620, $605, and $574, respectively. Earlier supporting developments included Synopsys outlining fiscal 2027 revenue of about $11.15 billion at the midpoint, a plan to return up to 50% of free cash flow through repurchases, and a $1 billion accelerated share repurchase agreement.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment